On the significance of the trigger reaction in the action of the calicheamicin γI1 anti-cancer drug

被引:29
|
作者
Lindh R. [1 ]
Ryde U. [1 ]
Schütz M. [1 ]
机构
[1] Theoretical Chemistry, Chemical Center, S-221 00 Lund
关键词
Bergman reaction; Calicheamicin; Integral-direct MP2; Parallel MP2; Trigger reaction;
D O I
10.1007/s002140050254
中图分类号
学科分类号
摘要
The significance of the so-called trigger reaction in the reaction mechanism of the calicheamicin γI1 anti-cancer drug has been studied with ab initio quantum chemical methods. The structures of four fragments of calicheamicin γI1, consisting of either 39 or 41 atoms, have been fully optimized using the Becke-Perdew86 density functional method and the 6-31G* basis sets. The four structures constitute members of an isodesmic reaction for which the reaction energy is a direct measure of the change in activation energy of the Bergman reaction, caused by the structural rearrangements of the preceding trigger reaction. This difference in activation energy has been calculated with density functional theory, using the exchange-correlation functional mentioned above, and with second-order Møller-Plesset perturbation theory (MP2), employing an ANO-type basis set. In both cases a value of 12 kcal/ mol is obtained. The study firmly supports the hypothesis that the significance of the trigger reaction is to saturate a double bond in the vicinity of the enediyne group, which counteracts the formation of the biradical state of the drug. The MP2 computations became feasible by a novel implementation of an integral-direct, distributed-data, parallel MP2 algorithm.
引用
收藏
页码:203 / 210
页数:7
相关论文
共 50 条
  • [21] Mechanisms of anti-cancer action and pharmacology of clofarabine
    Zhenchuk, Anna
    Lotfi, Koroush
    Juliusson, Gunnar
    Albertioni, Freidoun
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (11) : 1351 - 1359
  • [22] Anti-cancer drugs: Molecular mechanisms of action
    Isoldi, MC
    Visconti, MA
    Castrucci, AMD
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (07) : 685 - 695
  • [23] Retinoids as anti-cancer agents and their mechanisms of action
    Jin, Ying
    Teh, Soek Sin
    Lau, Harrison Lik Nang
    Xiao, Jianbo
    Mah, Siau Hui
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (03): : 938 - 960
  • [24] Flavonoids as anti-cancer agents and their mechanism of action
    Aydemir, Esra
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S81 - S81
  • [25] Anti-cancer drug sensitivity in sinonasal squamous cancer
    Garcia-Inclan, Cristina
    Lopez, Fernando
    Potes-Ares, Sira
    Llorente, Jose L.
    Hermsen, Mario
    CELLULAR ONCOLOGY, 2012, 35 : S46 - S46
  • [26] PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents
    Senevirathne, Suchithra A.
    Washington, Katherine E.
    Biewer, Michael C.
    Stefan, Mihaela C.
    JOURNAL OF MATERIALS CHEMISTRY B, 2016, 4 (03) : 360 - 370
  • [27] Phase 1 trials of Meditech's HyACT™ anti-cancer drug
    不详
    AUSTRALASIAN BIOTECHNOLOGY, 2002, 12 (04) : 18 - 18
  • [28] Sugen set to develop $1 bn anti-cancer drug - Pharmaceuticals
    不详
    EUROPEAN CHEMICAL NEWS, 1997, 67 (1761): : 23 - 23
  • [29] AQP1 as a new target for anti-cancer drug discovery
    Li, Xue-jun
    Gao, Jun-wei
    Zhang, Jian-zhao
    Xiang, Yang
    Ma, Bin
    Mu, Sheng-mei
    Song, Qian-liu
    Pan, Yan
    Yu, He-ming
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 28 - 28
  • [30] ψ-Bufarenogin, a lead compound of anti-cancer drug
    Ding, Jin
    Wang, Hongyang
    CELL CYCLE, 2015, 14 (17) : 2719 - 2720